Voigtländer V
J Int Med Res. 1977;5(2):128-31. doi: 10.1177/030006057700500210.
In a double-blind investigation, 36 patients suffering from various steroid-reponsive dermatoses were treated twice daily for three weeks either with 0-05% betamethasone 17,21-dipropionate cream or with 0-05% clobetasol propionate cream. Results showed both products to be highly effective in terms of onset of action and efficacy and no statistical differences were found (p greater than 0-1).
在一项双盲研究中,36例患有各种对类固醇有反应的皮肤病患者,每天接受两次治疗,为期三周,分别使用0.05%的倍他米松17,21 - 二丙酸酯乳膏或0.05%的丙酸氯倍他索乳膏。结果显示,两种产品在起效时间和疗效方面均非常有效,且未发现统计学差异(p大于0.1)。